Related Experiment Videos

The relation between endothelin-1 levels and myocardial injury in chronic ischemic heart failure

Mustafa Yazici1, Sabri Demircan, Kenan Durna

  • 1Department of Cardiology, Ondokuz Mayis University Medical School, 55139 Kurupelit, Samsun, Turkey. drmeyaz@hotmail.com

Heart and Vessels
|May 25, 2005
PubMed

Insights

Elevated endothelin-1 (ET-1) levels correlate with myocardial injury and reduced ejection fraction in chronic ischemic heart failure patients. This suggests ET-1 contributes to disease progression and cardiac dysfunction.

Area of Science:

  • Cardiology
  • Biochemistry
  • Heart Failure Research

Background:

  • Endothelin-1 (ET-1) is implicated in the progression of ischemic heart failure.
  • The relationship between ET-1 and myocardial injury markers needs further clarification.

Purpose of the Study:

  • To investigate the association between endothelin-1 (ET-1) levels and myocardial injury in patients with chronic ischemic heart failure.
  • To explore the correlation between ET-1, cardiac troponin-I (cTn-I), and ejection fraction.

Main Methods:

  • Cross-sectional study including 121 chronic ischemic heart failure patients and 37 healthy controls.
  • Measurement of plasma endothelin-1 (ET-1) and cardiac troponin-I (cTn-I) levels.
  • Echocardiographic assessment of ejection fraction and New York Heart Association (NYHA) functional classification.

Main Results:

  • ET-1 levels were significantly higher in heart failure patients than controls and increased with NYHA class severity.
  • Elevated cTn-I levels correlated with increased ET-1 and decreased ejection fraction.
  • A negative correlation was observed between ejection fraction and ET-1 levels (r = -0.312, P = 0.019).

Conclusions:

  • Increased ET-1 levels are associated with myocardial injury, indicated by elevated cTn-I.
  • ET-1 may contribute to the progression of chronic ischemic heart failure by exacerbating myocardial injury and reducing ejection fraction.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...